DAFTAR PUSTAKA

1. Yogev R, Chadwick EG. Acquired immunodeficiency syndrome (human

immunodeficiency virus). Dalam: Kliegman RM, Behrman RE, Jenson HB, Stanton BF,
penyunting. Nelson textbook of pediatrics. Edisi ke-18. New York: Elsevier’s; 2007.
1022- 32.

2. National AIDS Commission. 2007. National AIDS Commission 2007-2010 HIV and
AIDS Response Strategies.

3. Kementerian Kesehatan, DitJen. PP&PL. 2012. Laporan Situasi Perkembangan HIV dan
AIDS di Indonesia sd 30 Juni 2012.

4. Departemen Kesehatan Repubik Indonesia. Pedoman Tatalaksana dan Anti Terapi

Antiretroviral Pada Anak Indonesia. 2014

5. Carey, D., 1998, HIV/AIDS, dalam Hughes, J., Donnelly, R., dan James-Chatgilaov, G.,
Clinical Pharmacy: A Practical Approach, The Society of Hospital-Pharmacists of
Australia, Victoria

6. Corey, D.M., Kim, H.W., Salazar, R., Illescas, R., Villena, J., Gutierrez, L., Sanchez, J.,
and Tabet,S.R., 2007, Effectiveness of Combination Antiretroviral Therapy on Survival
and Opportunistic Infections in a Developing World Setting An Observational Cohort
Study, J Acquir. Immune Defic. Syndr., 44, 451–455.

7. Fletcher, C.V., and Kakuda, T.N., 2005, Human Immunodeficiency Virus Infection,
dalam Dipiro, J.T., Talbert, R.I., Yee, G.C., Maatzke, A., Wells, B.G., dan Passey, L.M.,
Pharmacotherapy: A Pathophysiologic Approach, 6th edition, Appleton and Lange,
Philadelphia.

8. Menkes RI. Peraturan Menteri Kesehatan Republik Indonesia No.51 Tahun 2013 tentang
Pedoman Pencegahan Penularan HIV dari Ibu ke anak . 2013. 08-10

9. IDAI. 2013. Pedoman Penerapan Terapi HIV Pada Anak

10. Price, Sylvia A., Wilson, Lorraine M. Patofisiologi Edisi 6 Volume 1. Jakarta.Penerbit
EGC. 2009: hal 417-418

11. National Department of Health, South Africa, South African National AIDS Council.
Clinical guidelines: PMTCT. South Africa: National Department of Health; 2010.

12. World Health Organization. Buku Saku Pelayanan Kesehatan Anak Di Rumah Sakit
Pedoman Bagi Rumah Sakit Rujukan Tingkat Pertama Di Kabupaten/Kota. 2010. 224-
245

13. Joint United Nations Programme on HIV/AIDS (UNAIDS).UNAIDS data tables 2011.
UNAIDS; 2011
14. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T,
dll. Efficacy of highly active antiretroviral therapy in HIVinfected children participating
in Thailand’s National Access to Antiretroviral Program.Clin Infect Dis2005;41:100-7.

15. Clavel F, Hance AJ. HIV drug resistance. N Engl J Med 2004;350:1023-35.

16. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkcs DR, Pillay 0, dkk.
Update of the resistance mutation in HIV-1: December 2010. Top HIV Med.
2010;18(5):156-63.

17. Llibre JM, Schapiro JM, Clotet B. Clinical implications of genotypic resistance to newer
antiretroviral drugs in ITTV-1-infected patients with virological failure. Clin Infect Dis.
2010;50:872-9.

18. Li JZ, Paredes R, Ribaudo IIJ. Low-frequency HIV-1 drug resistance mutation and risk
of NNRTl-based antiretroviral treatment failure: a systemic review and pooled analysis.
JAMA. 2011;305: L327-34.

19. Kozal M,J. Drug resistance testing in the clinical management of HIV infection.
[diunduh 2 Maret 2018). Tersedia dari: http//www.uptodate.com.

20. Fibriani A, Wisaksana R, Indrati A, Hartantri Y, van de Vijver D, Schutten M, et al.

Virological failure and drug resistance during first line anti-retroviral in Indonesia. J Med
Virol. 2013;85:1394-401.

21. Kusumaningrum A, Bela B, Ibrahim F, Yunihastuti E. Mutasi genetik dan resistensi obat
HIV (HIVDR) pada pasien terinfeksi HIV-1 gagal terapi setelah mendapat enam bulan
terapi antiretrovirus di RSUPN Ciptomangunkusumo periode September 2013–Maret
2014 [Tesis]. Jakarta: Universitas Indonesia; 2014.